Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of istradefylline in the Parkinson’s disease armamentarium
Thomas Müller
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 7, pp. 863-871
Closed Access | Times Cited: 11

Showing 11 citing articles:

James Parkinson and Other Historical Aspects of Parkinson’s Disease
Helen L. Dainton-Howard, Christopher G. Goetz
Neurologic Clinics (2025)
Closed Access
Treatment of Motor Symptoms of Parkinson’s Disease
Luca Marsili, Matteo Bologna, Lily Y. Chen, et al.
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 341-363
Closed Access
Structure–Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels
Alshaima’a M. Qunies, Brittany D. Spitznagel, Yu Du, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2437-2437
Open Access | Times Cited: 3
New drug discovery and development from natural products: Advances and strategies
Yixin Wang, Fan Wang, Wenxiu Liu, et al.
Pharmacology & Therapeutics (2024) Vol. 264, pp. 108752-108752
Closed Access | Times Cited: 2
Computational exploration of acefylline derivatives as MAO-B inhibitors for Parkinson’s disease: insights from molecular docking, DFT, ADMET, and molecular dynamics approaches
Ali Irfan, Ameer Fawad Zahoor, Yassir Boulaamane, et al.
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1
Effects of Intracerebral Aminophylline Dosing on Catalepsy and Gait in an Animal Model of Parkinson’s Disease
Érica de Moraes Santos Corrêa, Gustavo Christofoletti, Albert Schiaveto de Souza
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5191-5191
Open Access | Times Cited: 1
Real-world evidence on levodopa dose escalation in patients with Parkinson’s disease treated with istradefylline
Nobutaka Hattori, Daijiro Kabata, Shinji Asada, et al.
PLoS ONE (2023) Vol. 18, Iss. 12, pp. e0269969-e0269969
Open Access | Times Cited: 3
A review on the nutraceuticals of Parkinson's disease
Cassidy Vella, Renald Blundell
Journal of Food Nutrition and Diet Science (2024), pp. 51-65
Open Access
A novel hypothesis‐generating computational workflow utilizing reverse pharmacophore mapping—A drug repurposing perspective of istradefylline towards major depressive disorder
Mietha M. Van der Walt, Arnold Petrus Smith
British Journal of Pharmacology (2024)
Open Access
Bioengineered Exosomes: Cellular Membrane-Camouflaged Biomimetic Nanocarriers for Parkinson’s Disease Management
Maham Afzal, Huma Hameed, Ana Cláudia Paiva‐Santos, et al.
European Journal of Pharmacology (2024) Vol. 987, pp. 177199-177199
Closed Access
Recent Advancements in Parkinson\'s Disease
Sahil Mehta
Journal of Postgraduate Medicine Education and Research (2024) Vol. 58, Iss. 1, pp. 1-2
Open Access
Page 1

Scroll to top